 3. Patients with a non-inflammatory type of arthritis e.g. osteoarthritis or fibromyalgia that in the Investigators opinion is symptomatic enough to interfere with evaluation of the effect of study drug on the patients primary diagnosis of rheumatoid arthritis RA. 